Cleared Traditional

K122167 - NEXXIS OR

K122167 is the FDA 510(k) clearance for NEXXIS OR by Barco N.V.. It is a Class 2 Cardiovascular device (product code DXJ) cleared through the Traditional 510(k) pathway after a 273-day FDA review.

K122167 · Barco N.V. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2013
Decision
273d
Days
Class 2
Risk

K122167 is an FDA 510(k) clearance for the NEXXIS OR. Classified as Display, Cathode-ray Tube, Medical (product code DXJ), Class II - Special Controls.

Submitted by Barco N.V. (Kortrijk, BE). The FDA issued a Cleared decision on April 22, 2013 after a review of 273 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Barco N.V. devices

Submission Details

510(k) Number K122167 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 2012
Decision Date April 22, 2013
Days to Decision 273 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
148d slower than avg
Panel avg: 125d · This submission: 273d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXJ Display, Cathode-ray Tube, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXJ Display, Cathode-ray Tube, Medical

All 41
Devices cleared under the same product code (DXJ) and FDA review panel - the closest regulatory comparables to K122167.
CARESCAPE Central Station V2
K162012 · Ge Healthcare · Sep 2016
Philips CS770 IntelliSpace Critical Care and Anesthesia
K151366 · Philips Medical Systems · Oct 2015
SIVR56-T KIT
K133994 · Barco N.V. · Dec 2014
TLINK DATA MANAGEMENT SYSTEM (DMS)
K113214 · Terumo Cardiovascular Systems Corp. · Feb 2012
VANTAGE VIEW SYSTEM
K110085 · St Jude Medical · Jan 2011
INTELLIVUE CLINICAL INFORMATION PORTFOLIO
K100272 · Philips Medical Systems · Apr 2010